drugset / Trial / NCT04904952

Effect of N-acetylcysteine as Add on Therapy With SSRI in Moderate to Severe OCD Patients

NCT04904952

RandomizedParallel-groupDouble-blindTreatment

Summary

Title: Effect of n-acetylcysteine as add-on therapy with Selective Serotonin Reuptake Inhibitors in moderate to severe Obsessive Compulsive Disorder patients. Purpose of the study: To assess the effects of the addition of n-acetylcysteine with SSRIs on the severity of symptoms in obsessive-compulsive disorder patients.

Timeline

Start
2020-03-13
Primary completion
2022-01-10
Completion
2022-01-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator N-acetylcysteine Small molecule 2400 mg